These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 17038666)

  • 1. Impaired downregulation following erythropoietin receptor activation in non-small cell lung carcinoma.
    Dunlop EA; Maxwell AP; Lappin TR
    Stem Cells; 2007 Feb; 25(2):380-4. PubMed ID: 17038666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of erythropoietin and erythropoietin receptor in non-small cell lung carcinomas.
    Dagnon K; Pacary E; Commo F; Antoine M; Bernaudin M; Bernaudin JF; Callard P
    Clin Cancer Res; 2005 Feb; 11(3):993-9. PubMed ID: 15709164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CCAAT/enhancer binding protein homologous protein-dependent death receptor 5 induction and ubiquitin/proteasome-mediated cellular FLICE-inhibitory protein down-regulation contribute to enhancement of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by dimethyl-celecoxib in human non small-cell lung cancer cells.
    Chen S; Liu X; Yue P; Schönthal AH; Khuri FR; Sun SY
    Mol Pharmacol; 2007 Nov; 72(5):1269-79. PubMed ID: 17684158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An erythropoietin autocrine/paracrine axis modulates the growth and survival of human prostate cancer cells.
    Jeong JY; Hoxhaj G; Socha AL; Sytkowski AJ; Feldman L
    Mol Cancer Res; 2009 Jul; 7(7):1150-7. PubMed ID: 19567780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Curcumin sensitizes lung cancer cells to cisplatin-induced apoptosis through superoxide anion-mediated Bcl-2 degradation.
    Chanvorachote P; Pongrakhananon V; Wannachaiyasit S; Luanpitpong S; Rojanasakul Y; Nimmannit U
    Cancer Invest; 2009 Jul; 27(6):624-35. PubMed ID: 19283527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sprouty2 downregulation plays a pivotal role in mediating crosstalk between TGF-beta1 signaling and EGF as well as FGF receptor tyrosine kinase-ERK pathways in mesenchymal cells.
    Ding W; Shi W; Bellusci S; Groffen J; Heisterkamp N; Minoo P; Warburton D
    J Cell Physiol; 2007 Sep; 212(3):796-806. PubMed ID: 17516543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The proteasome inhibitor PS-341 (bortezomib) up-regulates DR5 expression leading to induction of apoptosis and enhancement of TRAIL-induced apoptosis despite up-regulation of c-FLIP and survivin expression in human NSCLC cells.
    Liu X; Yue P; Chen S; Hu L; Lonial S; Khuri FR; Sun SY
    Cancer Res; 2007 May; 67(10):4981-8. PubMed ID: 17510429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MDA-7/IL-24, a novel tumor suppressor/cytokine is ubiquitinated and regulated by the ubiquitin-proteasome system, and inhibition of MDA-7/IL-24 degradation enhances the antitumor activity.
    Gopalan B; Shanker M; Scott A; Branch CD; Chada S; Ramesh R
    Cancer Gene Ther; 2008 Jan; 15(1):1-8. PubMed ID: 17828282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant erythropoietin differently affects proliferation of mesothelioma cells but not sensitivity to cisplatin and pemetrexed.
    Palumbo C; Battisti S; Carbone D; Albonici L; Alimandi M; Bei R; Modesti A
    Cancer Chemother Pharmacol; 2008 Apr; 61(5):893-901. PubMed ID: 17922127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HOXB2, an adverse prognostic indicator for stage I lung adenocarcinomas, promotes invasion by transcriptional regulation of metastasis-related genes in HOP-62 non-small cell lung cancer cells.
    Inamura K; Togashi Y; Ninomiya H; Shimoji T; Noda T; Ishikawa Y
    Anticancer Res; 2008; 28(4B):2121-7. PubMed ID: 18751384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased PITX1 homeobox gene expression in human lung cancer.
    Chen Y; Knösel T; Ye F; Pacyna-Gengelbach M; Deutschmann N; Petersen I
    Lung Cancer; 2007 Mar; 55(3):287-94. PubMed ID: 17157953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of XIAP in inhibiting cisplatin-induced caspase activation in non-small cell lung cancer cells: a small molecule Smac mimic sensitizes for chemotherapy-induced apoptosis by enhancing caspase-3 activation.
    Checinska A; Hoogeland BS; Rodriguez JA; Giaccone G; Kruyt FA
    Exp Cell Res; 2007 Apr; 313(6):1215-24. PubMed ID: 17291493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-126 inhibits invasion in non-small cell lung carcinoma cell lines.
    Crawford M; Brawner E; Batte K; Yu L; Hunter MG; Otterson GA; Nuovo G; Marsh CB; Nana-Sinkam SP
    Biochem Biophys Res Commun; 2008 Sep; 373(4):607-12. PubMed ID: 18602365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Suppression of WIFI transcript and protein in non-small cell lung carcinomas].
    Korobko EV; Kalinichenko SV; Shepelev MV; Zborovskaia IB; Allakhverdiev AK; Zinov'eva MV; Vinogradova TV; Sverdlov ED; Korobko IV
    Mol Gen Mikrobiol Virusol; 2007; (2):13-8. PubMed ID: 17598452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulation of Sprouty2 in non-small cell lung cancer contributes to tumor malignancy via extracellular signal-regulated kinase pathway-dependent and -independent mechanisms.
    Sutterlüty H; Mayer CE; Setinek U; Attems J; Ovtcharov S; Mikula M; Mikulits W; Micksche M; Berger W
    Mol Cancer Res; 2007 May; 5(5):509-20. PubMed ID: 17510316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythropoietin receptor expression in non-small cell lung carcinoma: a question of antibody specificity.
    Brown WM; Maxwell P; Graham AN; Yakkundi A; Dunlop EA; Shi Z; Johnston PG; Lappin TR
    Stem Cells; 2007 Mar; 25(3):718-22. PubMed ID: 17110616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific components of prostanoid-signaling pathways are present in non-small cell lung cancer cells.
    Kreutzer M; Fauti T; Kaddatz K; Seifart C; Neubauer A; Schweer H; Kömhoff M; Müller-Brüsselbach S; Müller R
    Oncol Rep; 2007 Aug; 18(2):497-501. PubMed ID: 17611676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Up-regulation of 14-3-3zeta in lung cancer and its implication as prognostic and therapeutic target.
    Fan T; Li R; Todd NW; Qiu Q; Fang HB; Wang H; Shen J; Zhao RY; Caraway NP; Katz RL; Stass SA; Jiang F
    Cancer Res; 2007 Aug; 67(16):7901-6. PubMed ID: 17699796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Cell Type-Specific Differences in Erythropoietin Receptor Signaling in Primary Erythroid and Lung Cancer Cells.
    Merkle R; Steiert B; Salopiata F; Depner S; Raue A; Iwamoto N; Schelker M; Hass H; Wäsch M; Böhm ME; Mücke O; Lipka DB; Plass C; Lehmann WD; Kreutz C; Timmer J; Schilling M; Klingmüller U
    PLoS Comput Biol; 2016 Aug; 12(8):e1005049. PubMed ID: 27494133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythropoiesis-stimulating agent use in cancer: preclinical and clinical perspectives.
    Arcasoy MO
    Clin Cancer Res; 2008 Aug; 14(15):4685-90. PubMed ID: 18676735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.